Signature Care Acid Control
Loading...Signature Care Acid Control Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
- •
- with other acid reducers
- •
- if you have kidney disease, except under the advice and supervision of a doctor
- •
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- •
- nausea or vomiting
- •
- stomach pain
- •
- unexplained weight loss
- •
- frequent chest pain
- •
- frequent wheezing, particularly with heartburn
- •
- had heartburn over 3 months. This may be a sign of a more serious condition.
- •
- heartburn with lightheadedness, sweating or dizziness
- •
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- •
- your heartburn continues or worsens
- •
- you need to take this product for more than 14 days
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- •
- relieves heartburn associated with acid indigestion and sour stomach
- •
- prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Signature Care Acid Control Manufacturers
-
Safeway
![Signature Care Acid Control (Ranitidine) Tablet, Film Coated [Safeway]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Signature Care Acid Control | Aurobindo Pharma Limited
If significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box).
Concomitant administration of food does not adversely affect the absorption of clindamycin palmitate hydrochloride contained in clindamycin palmitate hydrochloride for oral solution (Pediatric).
Serious infections:8 to 12 mg/kg/day (4 to 6 mg/lb/day) divided into 3 or 4 equal doses.
Severe infections:13 to 16 mg/kg/day (6.5 to 8 mg/lb/day) divided into 3 or 4 equal doses.
More severe infections:17 to 25 mg/kg/day (8.5 to 12.5 mg/lb/day) divided into 3 or 4 equal doses.
In pediatric patients weighing 10 kg or less, ½ teaspoon (37.5 mg) three times a day should be considered the minimum recommended dose.
Serious infections due to anaerobic bacteria are usually treated with clindamycin injection. However, in clinically appropriate circumstances, the physician may elect to initiate treatment or continue treatment with clindamycin palmitate hydrochloride for oral solution (Pediatric).
NOTE:
In cases of β-hemolytic streptococcal infections, treatment should be continued for at least 10 days.
Reconstitution Instructions
When reconstituted with water as follows, each 5 mL (teaspoonful) of solution contains clindamycin palmitate hydrochloride equivalent to 75 mg clindamycin.
Reconstitute bottles of 100 mL with 75 mL of water. Add a large portion of the water and shake vigorously; add the remainder of the water and shake until the solution is uniform.
Storage Conditions
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Do NOT refrigerate the reconstituted solution; when chilled, the solution may thicken and be difficult to pour. The solution is stable for 2 weeks at room temperature.
Login To Your Free Account